Micron Biomedical
Atlanta, United States · Biotechnology, Health Care · 22 employees
Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to impro
Funding history
- Funding Round — $15.0M — Dec 2024
- Series seed — $3.0M — Apr 2023
- Funding Round — $14.0M — Dec 2022
- Series series a — Undisclosed — Nov 2022
Recent signals
- Jan 07, 2025: Micron Biomedical Secures $43 Million Grant to Improve Measles and Rubella Vaccine Coverage
- Dec 26, 2024: Raised $15.0M
- Apr 17, 2023: Raised $3.0M in Series seed
- Dec 07, 2022: Raised $14.0M
- Nov 28, 2022: Raised funding in Series series a
See plans & pricing → Track Micron Biomedical’s funding, hiring, and signals — with verified contacts — on Fundz.